The metabolic landscape of cancer stem cells

IUBMB Life - Tập 67 Số 9 - Trang 687-693 - 2015
Ilaria Dando1, Elisa Dalla Pozza1, Giulia Biondani1, Marco Cordani1, Marta Palmieri1, Massimo Donadelli1
1Department of Life and Reproduction Sciences, Section of Biochemistry, University of Verona, Verona, Italy

Tóm tắt

AbstractCancer stem cells (CSCs) are a sub‐population of quiescent cells endowed with self‐renewal properties that can sustain the malignant behavior of the tumor mass giving rise to more differentiated cancer cells. For this reason, the specific killing of CSCs represents one of the most important challenges of the modern molecular oncology. However, their particular resistance to traditional chemotherapy and radiotherapy imposes a thorough understanding of their biological and biochemical features. The metabolic peculiarities of CSCs may be a therapeutic and diagnostic opportunity in cancer research. In this review, we summarize the most significant discoveries on the metabolism of CSCs describing and critically analyzing the studies supporting either glycolysis or mitochondrial oxidative phosphorylation as a primary source of energy for CSCs. © 2015 IUBMB Life, 67(9):687–693, 2015

Từ khóa


Tài liệu tham khảo

10.1038/nm0797-730

10.3892/ijo.2014.2796

10.1158/1078-0432.CCR-12-0370

10.1038/nrc3597

10.1016/j.yexmp.2015.02.002

10.1038/aps.2013.27

10.1038/nrc1590

10.1038/bjc.2014.152

10.1038/bjc.2012.126

10.1016/j.cell.2011.11.025

10.1146/annurev.med.58.062105.204854

10.1373/clinchem.2012.184655

10.1038/cdd.2011.170

10.1158/0008-5472.CAN-06-3557

10.1097/MPA.0b013e31821ae25b

10.1186/1471-2407-12-44

10.1016/j.bbcan.2014.02.003

10.2174/1568011053765985

10.1517/13543784.15.1.23

10.3748/wjg.v21.i11.3232

10.1073/pnas.1421601112

Huang F., 2014, Expression of glutaminase is upregulated in colorectal cancer and of clinical significance, Int. J. Clin. Exp. Pathol, 7, 1093

10.1158/0008-5472.CAN-12-3461

10.1038/onc.2015.256

10.1016/j.ccr.2006.04.023

10.1158/0008-5472.CAN-15-0108

10.1126/science.1193494

10.1016/j.rcl.2007.05.004

10.3233/CBM-2011-0219

10.1007/s10549-013-2668-x

10.1016/j.biochi.2013.02.013

10.18632/oncotarget.2120

10.1016/j.bcp.2008.09.020

10.1186/s13046-015-0147-4

10.3389/fonc.2014.00262

10.4161/cc.24479

10.1007/s12015-009-9058-0

10.1016/j.stem.2010.07.007

10.1038/cdd.2013.131

10.1016/j.ccr.2013.01.022

10.1016/j.humpath.2015.05.010

10.1002/jso.23240

10.1016/j.ccr.2013.02.021

10.1155/2015/425708

10.1038/cddis.2014.285

10.1016/j.jprot.2013.06.027

10.1002/jcb.24671

10.1371/journal.pone.0084941

10.1074/jbc.M111.260935

10.1007/s00401-013-1173-y

10.1158/0008-5472.CAN-11-3024

10.4161/cc.27031

10.1073/pnas.1106704108

10.1038/nature13611

10.1101/gad.188292.112

10.18632/oncotarget.2010

10.1016/j.cell.2011.02.013

10.1016/j.stem.2012.12.013

10.1007/s10549-014-3051-2

10.1038/nn.3510